HanAll to initiate Phase I study for oral human growth hormone
The company plans to conduct its Phase I trial for HL-032 in the latter half of this year.
Company officials said the molecule is modi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
